Claims
- 1. A method of characterizing an agent, comprising,
treating a mammal cell or a mammal with an agent; and characterizing the DNA-interacting genotoxicity of said agent by determining the effect of said agent on expression in said mammal cell or mammal of at least one gene selected from the gene-set of Table 1.
- 2. A method of claim 1 wherein said characterizing of genotoxicity comprises characterizing said agent as either:
a) DNA-interacting genotoxic, if the agent causes an increase in expression of at least one gene selected from said gene-set, or b) of unknown DNA-interacting genotoxicity, if the agent does not cause an increase in expression of at least one gene selected from said gene-set.
- 3. A method of claim 2 wherein said characterizing of genotoxicity comprises characterizing said agent as either:
a) DNA-cross-linking genotoxic, if the agent causes an increase in expression of at least one gene selected from said gene-set, or b) of unknown DNA-cross-linking genotoxicity, if the agent does not cause an increase in expression of at least one gene selected from said gene-set.
- 4. A method of claim 1 wherein said characterizing step comprises determining the effect of said agent on expression of at least two genes selected from said gene-set.
- 5. A method of claim 2 wherein said characterizing step comprises determining the effect of said agent on expression of at least two genes selected from said gene-set.
- 6. A method of claim 1 wherein said characterizing step comprises determining the effect of said agent on expression of at least three gene selected from said gene-set.
- 7. A method of claim 2 wherein said characterizing step comprises determining the effect of said agent on expression of at least three gene selected from said gene-set.
- 8. A method of claim 1 wherein the effect of said agent on expression is determined for at least two genes comprising gene accession numbers AV138783 and AI847051.
- 9. A method of claim 2 wherein the effect of said agent on expression is determined for at least two genes comprising gene accession numbers AV138783 and AI847051.
- 10. A method of claim 1 wherein the effect of said agent on expression is determined for at least three genes comprising gene accession numbers AV138783, AI847051 and AF55638.
- 11. A method of claim 2 wherein the effect of said agent on expression is determined for at least three genes comprising gene accession numbers AV138783, AI847051 and AF55638.
- 12. A method of characterizing the genotoxicity of an agent, comprising:
treating a mammal cell or a mammal with an agent; and determining the effect of said agent on expression in said mammal cell or mammal of at least one gene selected from gene accession numbers AV138783, AI847051, AF055638 and AI461837.
- 13. A method of claim 1 wherein said mammal cell or mammal is a mouse cell or a mouse.
- 14. A method of claim 2 wherein said mammal cell or mammal is a mouse cell or a mouse.
- 15. A method of claim 3 wherein said mammal cell or mammal is a mouse cell or a mouse.
- 16. A method of claim 12 wherein said mammal cell or mammal is a mouse cell or a mouse.
CROSS REFERENCE TO RELATED APPLICATION
[0001] This application claims the benefit of U.S. Provisional Application No. 60/375,784 filed Apr. 26, 2002.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60375784 |
Apr 2002 |
US |